For osteoclast formation assays, BMMs seeded in 96-well plates at a density of 8×103 cells/well in complete α-MEM containing 30 ng/ml M-CSF and 50 ng/ml RANKL were treated without or with various concentrations (5–20 μM) of Preg for 7 d. Medium containing M-CSF, RANKL, and Preg were changed every 2 d. At the end of 7 d, cells were fixed with 4% paraformaldehyde (PFA) for 20 min and stained for TRAP activity. TRAP stained cells were imaged under light microscopy and the number and size (in terms of area) of TRAP+ve multinucleated osteoclasts with three or more nuclei were quantified using ImageJ software. For bone resorption assays, BMMs were cultured in six-well plates with 30 ng/ml M-CSF and 50 ng/ml RANKL for 3–4 d until small pre-osteoclast-like cells formed. Removed the cells with trypsin for 3 min and gently scraped them off and then centrifuge at 1,000 rpm for 5 min. Then equally reseed the cells onto hydroxyapatite-coated plates. Let the cells settle for 8 h, then treated with various concentrations (5, 10, and 20 μM) of Preg. After 4 d, adherent cells were incubated with 5% sodium hypochlorite solution for 15 min and then washed three times with PBS. Plates were air-dried and resorption pits visualized under light microscopy. The percentage of resorbed area relative to total well area for each experimental condition were measured using ImageJ software.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.